THE Renal Center Of Guayama is a medicare approved dialysis facility center in Guayama, Puerto Rico and it has 23 dialysis stations. It is located in Guayanilla county at Bo Algarrobo, Guayama, PR, 00785. You can reach out to the office of THE Renal Center Of Guayama at (787) 986-5049. This dialysis clinic is managed and/or owned by Atlantis Healthcare Group. THE Renal Center Of Guayama has the following ownership type - Profit. It was first certified by medicare in January, 2017. The medicare id for this facility is 402556 and it accepts patients under medicare ESRD program.
| Name | THE Renal Center Of Guayama |
|---|---|
| Location | Bo Algarrobo, Guayama, Puerto Rico |
| No. of Dialysis Stations | 23 |
| Medicare ID | 402556 |
| Managed By | Atlantis Healthcare Group |
| Ownership Type | Profit |
| Late Shifts | No |
| Bo Algarrobo, Guayama, Puerto Rico, 00785 | |
| (787) 986-5049 | |
| Not Available |
News Archive
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc., announced today it received notice from the U.S. Food and Drug Administration (FDA) that having successfully met requirements for improvements to the quality system, the company may resume unrestricted worldwide shipments of its external defibrillators.
Sunbathers wearing sunscreen labeled as "high protection" did not spend more time in the sun during a week-long vacation compared to those wearing "basic protection" sunscreen, according to an article in the August issue of Archives of Dermatology.
Contrary to popular belief across college campuses, attention deficit hyperactivity disorder medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University.
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 2 |
News Archive
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc., announced today it received notice from the U.S. Food and Drug Administration (FDA) that having successfully met requirements for improvements to the quality system, the company may resume unrestricted worldwide shipments of its external defibrillators.
Sunbathers wearing sunscreen labeled as "high protection" did not spend more time in the sun during a week-long vacation compared to those wearing "basic protection" sunscreen, according to an article in the August issue of Archives of Dermatology.
Contrary to popular belief across college campuses, attention deficit hyperactivity disorder medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University.
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 24 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 108 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc., announced today it received notice from the U.S. Food and Drug Administration (FDA) that having successfully met requirements for improvements to the quality system, the company may resume unrestricted worldwide shipments of its external defibrillators.
Sunbathers wearing sunscreen labeled as "high protection" did not spend more time in the sun during a week-long vacation compared to those wearing "basic protection" sunscreen, according to an article in the August issue of Archives of Dermatology.
Contrary to popular belief across college campuses, attention deficit hyperactivity disorder medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University.
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
› Verified 1 days ago
| Adult patients getting regular peritoneal dialysis at the center | 4 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 9 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc., announced today it received notice from the U.S. Food and Drug Administration (FDA) that having successfully met requirements for improvements to the quality system, the company may resume unrestricted worldwide shipments of its external defibrillators.
Sunbathers wearing sunscreen labeled as "high protection" did not spend more time in the sun during a week-long vacation compared to those wearing "basic protection" sunscreen, according to an article in the August issue of Archives of Dermatology.
Contrary to popular belief across college campuses, attention deficit hyperactivity disorder medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University.
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at THE Renal Center Of Guayama with elevated calcium levels.
| Patients with hypercalcemia | 28 |
| Hypercalcemia patient months | 117 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
| Patients with Serumphosphor | 30 |
| Patients with Serumphosphor less than 3.5 mg/dL | |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | |
| Patients with Serumphosphor greater than 7 mg/dL |
News Archive
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc., announced today it received notice from the U.S. Food and Drug Administration (FDA) that having successfully met requirements for improvements to the quality system, the company may resume unrestricted worldwide shipments of its external defibrillators.
Sunbathers wearing sunscreen labeled as "high protection" did not spend more time in the sun during a week-long vacation compared to those wearing "basic protection" sunscreen, according to an article in the August issue of Archives of Dermatology.
Contrary to popular belief across college campuses, attention deficit hyperactivity disorder medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University.
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 5 |
| Patient months included in arterial venous fistula and catheter summaries | 24 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc., announced today it received notice from the U.S. Food and Drug Administration (FDA) that having successfully met requirements for improvements to the quality system, the company may resume unrestricted worldwide shipments of its external defibrillators.
Sunbathers wearing sunscreen labeled as "high protection" did not spend more time in the sun during a week-long vacation compared to those wearing "basic protection" sunscreen, according to an article in the August issue of Archives of Dermatology.
Contrary to popular belief across college campuses, attention deficit hyperactivity disorder medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University.
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc., announced today it received notice from the U.S. Food and Drug Administration (FDA) that having successfully met requirements for improvements to the quality system, the company may resume unrestricted worldwide shipments of its external defibrillators.
Sunbathers wearing sunscreen labeled as "high protection" did not spend more time in the sun during a week-long vacation compared to those wearing "basic protection" sunscreen, according to an article in the August issue of Archives of Dermatology.
Contrary to popular belief across college campuses, attention deficit hyperactivity disorder medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University.
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
› Verified 1 days ago